US Patent 7754714 Cycloalkyl substituted pyrimidinediamine compounds and their uses
Patent 7754714 was granted and assigned to Rigel Pharmaceuticals on July, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+283 characters)
Article
Patent abstract
The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Ankush Argade0
David Carroll0
Hui Li0
John McLaughlin0
Kin Tso0
Rajinder Singh0
Sambaiah Thota0
Vadim M. V. Markovtsov0
Vanessa Taylor0
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07754714 Cycloalkyl substituted pyrimidinediamine compounds and their uses US Patent 7754714 Cycloalkyl substituted pyrimidinediamine compounds and their uses
Infobox
Patent Number
07754714
Patent Number
7754714
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07754714 Cycloalkyl substituted pyrimidinediamine compounds and their uses
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07754714
Date of patent
July 13, 2010
Patent application number
11133419
Date Filed
May 18, 2005
Patent primary examiner
Find more entities like US Patent 7754714 Cycloalkyl substituted pyrimidinediamine compounds and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
